Self-Hemotherapy for the Treatment of one Case of Hyperglycemia

  • Mengdan Zhang Shaanxi University of Traditional Chinese Medicine
  • Zhengquan Lei The Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine
DOI: https://doi.org/10.18686/aem.v11i3.280
Keywords: Autohemotherapy, Type 2 Diabetes, Acupuncture, Hyperglycemia, Case Analysis

Abstract

The clinical use of autohemotherapy for the treatment of hyperglycemia in type 2 diabetes mellitus has a remarkable effect.

References

[1] Lu ZY, Zhong NS. Internal Medicine[M].7th edition. Beijing: People's Medical Publishing House, 2008, 770-793.

[2] Zhang Q, Wang ZJ, Zhou YR, Gao HL. Expert interpretation of the 2022 clinical guidelines for the prevention and treatment of type 2 diabetes in the elderly in China[J].Journal of Intractable Diseases, 2022, 21(05): 445-449.

[3] Li ZW, Huang JF, Wen J, et al. Metabolomics of serum and feces in patients with type 2 diabetes[J]. Journal of Kunming Medical University, 2021, 42(02): 54-63.

[4] Chinese Prediabetes Clinical Intervention Expert Group.Expert consensus on prediabetes clinical intervention in China (Draft for Solicitation of Comments) [J]. Drug Evaluation, 2019, 16(7):3-12, 16.

[5] Zhang YT, Liu SP. Adverse reactions of metformin in the treatment of type 2 diabetes mellitus and its application in combination[J].Medical Information, 2021, 34 (06): 64-68.

[6] Wang AN, Li H, Shi Y, et al. Reticular Meta-Analysis and Safety Evaluation of Acupuncture for the Treatment of Diabetic Peripheral Neuropathy[J]. World Journal of Traditional Chinese Medicine, 2021,16(21):3225-3236.

[7] Lei ZQ, Wang QH. Fundamentals of Acupuncture[M]. Shaanxi: Xi'an Jiaotong University Press.2016.463.

[8] Lun ZG. Literature study of traditional Chinese medicine on common chronic complications of diabetes mellitus (thirst quenching disease)[D]. China Academy of Chinese Medical Sciences, 2010.
Published
2022-11-04
Issue
Vol 11 No 3 (2022)
Section
Original Research Article

Copyright (c) 2022 Mengdan Zhang, Zhengquan Lei

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear

Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.